Sam Altman, CEO of OpenAI, returns to lead the company after a dramatic departure. Winners and losers in OpenAI's recent developments are discussed, highlighting Microsoft as a winner. The global water shortage and its impact on climate change are explored. The challenges faced by the healthcare workforce during the pandemic are examined. The impact of a specific drug on appetite, weight loss, and productivity enhancement is discussed. The podcast also touches on market closure for Thanksgiving and money management.
Read more
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
Prescriptions for appetite-reducing drugs like O'Zempic have led to healthier food choices and portion control during holidays like Thanksgiving.
The market shows positive signals for the end of 2023 and 2024, with small-cap stocks performing well and 20-year treasuries becoming more attractive.
Deep dives
Prescriptions for GLP1 agonists quadruple as Americans eat less
Prescriptions for drugs like O'Zempic and VWG-Goodwing have quadrupled in recent years. These medications reduce appetite and have led many people to eat less. Patients taking these drugs report having a different perspective on food and are more mindful of their portion sizes. As a result, some individuals are making healthier food choices and incorporating more fruits, vegetables, and protein into their diets. The use of these drugs has had a significant impact on how people approach food during holidays like Thanksgiving.
Market outlook: Bullish for end of 2023, positive for 2024
The market has been challenging to trade in recent months, but there are positive signs for the end of 2023 and 2024. The HCM buy line, an intermediate-term trend system, has turned positive, indicating a bullish trend. The market is showing signs of broadening, with small-cap stocks and the Russell 2000 performing well. Additionally, the bond market is looking healthier, with 20-year treasuries becoming more attractive. Overall, there is optimism for a strong end to 2023 and a positive outlook for 2024.
Investment strategy: Focus on domestic markets
While international markets have been discussed as attractive in the past, the focus should be on domestic markets currently. With a more reliable and powerful performance, US markets offer greater opportunities for investment. Vance Howard suggests that international equities are not as appealing and recommends focusing on the domestic market for investment opportunities.
Bloomberg Intelligence Senior Technology Analyst Mandeep Singh and Bloomberg Technology Executive Editor Tom Giles discuss Sam Altman heading back to lead OpenAI less than five days after he was pushed out of one of the world’s most valuable startups, setting off a shock back-and-forth drama that transfixed Silicon Valley and the global AI industry. Rich Lesser, Global Chair of BCG, talks about evaluating corporate climate and sustainability commitments. Aloha McBride, EY Global Health Leader, shares the findings of the firm's Global Voices in Healthcare Study. Bloomberg News Consumer Reporter Deena Shanker provides the details of her Businessweek story ‘I Don’t Think About Food as Much’: Ozempic Rocks Thanksgiving. And we Drive to the Close with Vance Howard, CEO at Howard Capital Management. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.